Advisor Group Holdings, Inc. Magenta Therapeutics, Inc. Transaction History

Advisor Group Holdings, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$0.97 - $3.08 $119 - $378	-123 Closed	0 $0
Q3 2021 Nov 05, 2021	BUY	$6.07 - $9.89 $746 - $1,216	123 New	123 $1,000
Q1 2021 May 13, 2021	SELL	$7.66 - $13.38 $7,660 - $13,380	-1,000 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$6.52 - $8.94 $6,520 - $8,940	1,000 New	1,000 $7,000

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.